Screener
Solesence, Inc. SLSN Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $1.05M-74.5% | $573K-68.5% | $1.29M-8.6% | $429K-85.3% | $4.11M+74.2% | ||
| $10.24M-17.9% | $7.25M-28.1% | $7.64M+35.1% | $11.44M+31.0% | $12.47M+110% | ||
| $12.96M-34.7% | $13.82M-37.0% | $14.96M-26.2% | $18.87M+25.4% | $19.83M+42.9% | ||
| $25.27M-34.8% | $22.67M-36.9% | $25.23M-14.0% | $32.79M+10.2% | $38.77M+59.8% | ||
| $14.79M+9.1% | $14.75M+12.5% | $14.33M+12.5% | $13.94M+36.2% | $13.56M+46.4% | ||
| $46.44M-22.5% | $44.05M-22.7% | $46.51M-7.0% | $53.99M+12.4% | $59.96M+46.8% | ||
| $4.97M-27.9% | $4.67M-49.0% | $4.1M-54.9% | $4.83M-26.5% | $6.89M+23.6% | ||
| $1.94M-10.7% | $1.17M-74.8% | $930K-83.3% | $1.2M-80.8% | $2.17M-29.5% | ||
| $26.01M+15.4% | $12.69M-61.4% | $13.93M-46.0% | $17.86M-23.3% | $22.54M+63.7% | ||
| —— | $1M— | $1M— | $1M— | $1M0.0% | ||
| $7.27M-62.2% | $18.14M+102% | $18.49M+99.2% | $18.9M+97.0% | $19.23M+26.9% | ||
| 95M0.0% | 95M0.0% | 95M+13,471% | 95M0.0% | 95M0.0% | ||
| -$103.31M-5.8% | -$103.15M-2.8% | -$102.19M-1.8% | -$98.8M+1.1% | -$97.68M+5.1% | ||
| $13.15M-8.8% | $13.22M+22.1% | $14.09M+36.1% | $17.23M+13.6% | $14.42M+21.0% | ||
| $46.44M-22.5% | $44.05M-22.7% | $46.51M-7.0% | $53.99M+12.4% | $59.96M+46.8% |
FAQ
- What are Solesence, Inc.'s total assets?
- Solesence, Inc. (SLSN) holds $46.4M in total assets, down 22.6% year over year.
- How much debt does Solesence, Inc. have?
- Solesence, Inc. carries $8.4M in total debt against $13.2M of shareholders' equity, a debt-to-equity ratio of 0.64.
- How much cash does Solesence, Inc. have?
- Solesence, Inc. holds $1.0M in cash and equivalents.
- Can Solesence, Inc. cover its short-term obligations?
- Its current ratio is 0.97 — current liabilities exceed current assets.
- Where does Solesence, Inc.'s balance sheet data come from?
- Every line is extracted from Solesence, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
